United States · Who invested in Exicure?
Exicure's investors include Knoll Ventures, Purple Arch and Luye Pharma Group/ Eager Info Investments.
United States · Funded startup
Who invested in Exicure
Funding summaryUpdated 26 Oct 2026
$11Mraised across 1 round since 2017, from 1 source
- Latest round
- Round, $11MNov 2017
- Investors
- 3
The rounds
- Nov 2017Round$11M
Knoll Ventures- Purple Arch
- Luye Pharma Group/ Eager Info Investments
Reported by BusinesswireSEC filing: $43M sold, first sale Sept 2017
Founders and team
From the SEC filings it signed: 4 on the team.
- David A. GiljohannExecutive Officer, Directori
- David S. SnyderExecutive Officeri
- Ekambar R. KandimallaExecutive Officeri
- Matthias R. SchroffExecutive Officeri
On the board, as filediC. Shad ThaxtonChad MirkinDavid R. WaltHelen S. KimJay R. Venkatesan
Everyone who backed them
Purple ArchVC firm1round
Luye Pharma Group/ Eager Info Investmentsno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Exicure
How much has Exicure raised?
Exicure has raised $11M across 1 round since 2017.
When did Exicure last raise?
Exicure's most recent round was an Undisclosed round of $11M in Nov 2017.
What was Exicure's biggest round?
Its most recent round, $11M in Nov 2017, is also its largest on record.
Who backed Exicure first?
Exicure's first round on record, in Nov 2017, was backed by Knoll Ventures, Purple Arch and Luye Pharma Group/ Eager Info Investments.
What stage is Exicure at?
Exicure's latest named round is an Undisclosed round, in Nov 2017.
Where is Exicure based?
Exicure is based in the United States.
Companies like Exicure
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.